News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Israel firm has high hopes for new cancer-busting drug

Al's Comment:

 They reported great phase 2 trial results - a doubling of the % of recurrent glioblastoma patients alive at the 1 year point, compared to historical controls. They also showed a great dose response curve, which indicates that the treatment effect is real. They are now doing a large phase 3 trial for recurrent gbm.

Posted on: 11/30/2016

Israel firm has high hopes for new cancer-busting drug


Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557